AzTrials
AzTrials

Chronic Venous InsufficiencyNCT05982405

Long-term Effects of Inspiratory Muscle Training in Chronic Venous Insufficiency

A study testing Training group: Inspiratory muscle training in people with Chronic Venous Insufficiency, run by Izmir Democracy University at 1 site in Turkey (Türkiye).

Terminated

Stopped early. The study ended before it was planned to and will not resume.

Official record
Search all trials

Trial summary

The long-term effectiveness of inspiratory muscle training, which is known in the literature to help venous return by increasing the pump effect of the diaphragm muscle, remains unclear in individuals with chronic venous insufficiency. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Chronic Venous Insufficiency
What is being tested?
Training group: Inspiratory muscle training
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
40 participants
Where
1 siteTurkey (Türkiye)
Study dates
15 Sep 2023to 30 Dec 2024
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • 18 years of age or older
  • Volunteering to participate in the study
  • Diagnosed with chronic venous insufficiency using duplex ultrasound and being under standard medical treatment follow-up
  • Being in one of the C1, C2, C3, C4 or C5 stages according to the Clinical, Etiology, Anatomy and Pathophysiology (CEAP) classification

Who cannot join

  • Acute deep vein thrombosis, active ulcers, psychiatric disorder requiring prior vessel ablation and/or prescription drug therapy,
  • Any history of chronic disease or deep vein thrombosis that may interfere with exercise capacity measurement,
  • Having SARS-CoV-2 (COVID-19) or any acute infection,
  • Being pregnant,
  • History of arterial disease,
  • Having advanced cardiorespiratory diseases, acute ulcer (< 3 months) and diabetic ulcers.

Trial locations and contacts

1 site in 1 country.

Turkey (Türkiye)1 site
  • Izmir Democracy University

    Izmir, 35140

Other trials in Turkey (Türkiye)

About this study

Official title: Long-term Effects of Inspiratory Muscle Training in Individuals With Chronic Venous Insufficiency

The long-term effectiveness of inspiratory muscle training, which is known in the literature to help venous return by increasing the pump effect of the diaphragm muscle, remains unclear in individuals with chronic venous insufficiency. For this reason, in this study, it was aimed to investigate the long-term results of inspiratory muscle training in individuals with chronic venous insufficiency.

Read the detailed description

Initial treatment of chronic venous insufficiency (CVI) includes conservative methods such as reducing symptoms and helping to prevent secondary problems and disease progression. If conservative methods fail, further treatments based on anatomical and physiological pathophysiological features should be applied. Treatment of CVI ranges from simple compression stockings to very complicated venous reconstructions. Physiotherapy applications also have an important place in the treatment of CVI and contain patient education, complex decongestive physiotherapy, intermittent pneumatic compression, compression garment, venous exercise programs, biomechanical stimulation therapy, proprioceptive neuromuscular facilitation, relaxation techniques and hydrotherapy methods.

Researches investigating the effectiveness of new physiotherapy applications in CVI are very limited. In one of these publications, the effects of inspiratory muscle training (IMT) and calf muscle exercise training (CMET) applied in addition to compression therapy (CT) on quality of life (QoL), venous filling time, disease severity, pain, edema, range of motion, muscle strength and functionality were investigated newly. IMT and CT were applied in group 1, CMET and CT were applied in group 2, and only CT was applied in group 3. As a result, groups of 1 and 2 showed more improvement in these outcomes compared to other groups. Acute effects of inspiratory muscle training in CVI was only shown in this study. The long-term effectiveness of inspiratory muscle training is still unclear in individuals with CVI. Therefore, this study aimed to investigate the long-term results of inspiratory muscle training in individuals with CVI.

Being tested
Training group: Inspiratory muscle training, Control group: Thoracic expansion exercise
Keywords
Venous Insufficiency, pain, edema, respiratory function tests, maximal respiratory pressures, exercise capacity, quality of life
Medical subject headings
Venous Insufficiency, Pain, Edema

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Training group: Inspiratory muscle trainingOther

    Also called Experimental: Training group

    The individuals in the training group will be performed inspiratory muscle training at 30-50% of the maximal inspiratory pressure. Inspiratory muscle training will be done using an inspiratory muscle training device (PowerBreathe®) that works with the threshold loading principle. Inspiratory muscle training will be done for 15 minutes per a session, 2 times per a day or, if tolerated, 30 minutes per a day and 1 time per a day, 5-7 days/week (one session under the supervision and the others at home), for a total of 6 weeks. Applications made at home will be followed with a diary.

  • Control group: Thoracic expansion exerciseOther

    Also called Sham Comparator: Control group

    Individuals in the control group will be performed thoracic expansion exercises. Thoracic expansion exercises will be applied to individuals in an upright sitting position. In this position, individuals will place their hands on their lower ribs and then perform the cycle of "deep breathing + holding the deep breath for 3 seconds + slowly emptying all the breath" 3 times in a row. After this cycle, individuals will be asked to rest by taking 3-4 calm breaths. Immediately after, the individual will be asked to repeat the same cycle and repeat the cycle with calm breaths and rest until it reaches 10 repetitions. The individual will do this session 4 times a day. Individuals will do the first session of breathing exercises under supervision. In this way, incorrect exercise will be prevented. Other breathing exercise sessions will be done by individuals as a home program every day and 4 sessions a day during 6 weeks.

Study groups in NCT05982405
Study groupRoleWhat they receive
Training groupExperimentalThe individuals in the training group will be performed inspiratory muscle training using an inspiratory muscle training device (PowerBreathe®) at 30-50% of the maximal inspiratory pressure.
Receives: Other: Training group: Inspiratory muscle training
Control groupSham comparatorIndividuals in the control group will be performed thoracic expansion exercises.
Receives: Other: Control group: Thoracic expansion exercise

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Maximal inspiratory pressure (MIP)

    The MIP which shows respiratory muscle strength will be evaluated using a portable mouth pressure measuring device based on American Thoracic Society and European Respiratory Society criteria.

    Measured: After 6-week training and 3 months after 6-week training ends.

Secondary outcomes (10)
  1. Maximal expiratory pressure (MEP)

    The MEP which shows respiratory muscle strength will be evaluated using a portable mouth pressure measuring device based on American Thoracic Society and European Respiratory Society criteria.

    Measured: After 6-week training and 3 months after 6-week training ends.

  2. Forced vital capacity (FVC)

    Pulmonary function (Forced vital capacity (FVC)) will be evaluated with a spirometer.

    Measured: After 6-week training and 3 months after 6-week training ends.

  3. Forced expiratory volume in the first second (FEV1)

    Pulmonary function (Forced expiratory volume in the first second (FEV1)) will be evaluated with a spirometer.

    Measured: After 6-week training and 3 months after 6-week training ends.

  4. FEV1 / FVC

    Pulmonary function (FEV1 / FVC) will be evaluated with a spirometer.

    Measured: After 6-week training and 3 months after 6-week training ends.

  5. Flow rate 25-75% of forced expiratory volume (FEF 25-75%)

    Pulmonary function (Flow rate 25-75% of forced expiratory volume (FEF 25-75%)) will be evaluated with a spirometer.

    Measured: After 6-week training and 3 months after 6-week training ends.

  6. Peak flow rate (PEF)

    Pulmonary function (Peak flow rate (PEF)) will be evaluated with a spirometer.

    Measured: After 6-week training and 3 months after 6-week training ends.

  7. Pain Intensity measured with the Numerical Rating Scale.

    Pain intensity will be measured with the Numerical Rating Scale. This scale expresses the severity of pain with integers from 0 (no pain) to 10 (the worst possible pain).

    Measured: After 6-week training and 3 months after 6-week training ends.

  8. Aerobic capacity

    The six-minute walk test (6-MWT) will be performed according to the criteria of the American Thoracic Society for the evaluation of aerobic capacity.

    Measured: After 6-week training and 3 months after 6-week training ends.

  9. Lower extremity strength

    To determine lower extremity strength and functional mobility, the 30-second Sit-Up Test will be used in the chair.

    Measured: After 6-week training and 3 months after 6-week training ends.

  10. Total quality of life score evaluated by Chronic Venous Disease Quality of Life Questionnaire

    The score will be evaluated using Chronic Venous Disease Quality of Life Questionnaire. Each question is scored on a 5-item Likert scale. Higher scores indicate better quality of life.

    Measured: After 6-week training and 3 months after 6-week training ends.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted8 Aug 2023
  2. Study start15 Sep 2023
  3. Primary completion30 Jun 2024
  4. Study completion30 Dec 2024

Why it stopped: Patients could not be reached for long-term follow-up.

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Randomised
Intervention model
Parallel groups
Masking
Single blind
Who is masked
Participant
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT05982405
Sponsor's protocol ID
Long effects of IMT
Status last verified
May 2025
First submitted
28 Jul 2023
Last updated
18 May 2025
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
No

Publications

  • Aydin G, Yeldan I, Akgul A, Ipek G. Effects of inspiratory muscle training versus calf muscle training on quality of life, pain, venous function and activity in patients with chronic venous insufficiency. J Vasc Surg Venous Lymphat Disord. 2022 Sep;10(5):1137-1146. doi: 10.1016/j.jvsv.2022.04.012. Epub 2022 Jun 14.

    PubMed 35710091
  • Weiss RA, Munavalli G. Endovenous ablation of truncal veins. Semin Cutan Med Surg. 2005 Dec;24(4):193-9. doi: 10.1016/j.sder.2005.10.006.

    PubMed 16387263
  • Eberhardt RT, Raffetto JD. Chronic venous insufficiency. Circulation. 2005 May 10;111(18):2398-409. doi: 10.1161/01.CIR.0000164199.72440.08. No abstract available.

    PubMed 15883226

Questions about this trial

What is this clinical trial studying?

A study testing Training group: Inspiratory muscle training in people with Chronic Venous Insufficiency, run by Izmir Democracy University at 1 site in Turkey (Türkiye).

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: stopped early, as of the sponsor's last update on 18 May 2025. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Turkey (Türkiye). Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study was stopped early (reason given: Patients could not be reached for long-term follow-up.). Results are not available in the source record.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Maximal inspiratory pressure (MIP) (time frame: After 6-week training and 3 months after 6-week training ends.). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT05982405, which also lists 3 linked publications.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 18 May 2025.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in